Figure 3.
Kaplan–Meier analysis of the differences in the risk of metabolic syndrome between the treatment groups (P > 0.05 by the log-rank test).
Kaplan–Meier analysis of the differences in the risk of metabolic syndrome between the treatment groups (P > 0.05 by the log-rank test).